$30.680
+0.021 (+0.07%)收盘时
PHVS 盈利能力与利润率
Evaluating the bottom line, Pharvaris N.V. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -70.46%, provide a clear picture of how effectively PHVS converts its operational activities into shareholder value.
PHVS 同业对比
In the context of the broader market, PHVS competes directly with industry leaders such as IMNM and ALVO. With a market capitalization of $2.09B, it holds a significant position in the sector. When comparing efficiency, PHVS's gross margin of N/A stands against IMNM's N/A and ALVO's 50.71%. Such benchmarking helps identify whether Pharvaris N.V. is trading at a premium or discount relative to its financial performance.
Pharvaris NV 财务表现
Pharvaris has reported consistent net losses, with the latest loss at €47.8 million for Q2 2026, and a negative EPS of -0.70. Despite this, the company has a strong current ratio of 11.94, indicating good liquidity.
Financials
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。